Neoadjuvant Short-Course Radiotherapy Followed by CAPOX Plus PD-1 Antibody and IL-2 in Locally Advanced Rectal Cancer (PRIDE01)
Clinical trial NCT06577194 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06577194
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-09
- Primary completion
- 2026-06-10
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.